 |
|
|
| |
Resistance Analyses During Treatment of Lenacapavir with Broadly Neutralizing Antibodies in People with HIV
|
| |
| |
AIDS 2024 July 20-26 Munich
Lisa Selzer1*, Sally Demirdjian1, Ross Martin1, Brie Falkard1, Sean E. Collins1, Joseph Eron2, Laurie A. VanderVeen1, Christian Callebaut1
1Gilead Sciences, Inc., Foster City, CA, USA; 2University of North Carolina, Chapel Hill, NC, USA
*Presenting Author
|
| |
|
|
|
|
|
